Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ex vivo effect of aminaftone (Capillarema) on endothelial function in systemic sclerosis
2006-005230-20Phase 3Active
- Sponsor
- Policlinico di Milano
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of aminaphthone in systemic sclerosis (SSc) and Raynaud disease, sponsored by Policlinico di Milano. Primary endpoint: Change in plasma markers of endothelial damage. Started Jul 2007; status: active.
02
Drugs
aminaphthone
03
Conditions
systemic sclerosis (SSc)Raynaud disease
Beyond the preview
Go deeper on 2006-005230-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005230-20.